Showing Results for
- Academic Journals (1,849)
Search Results
- 1,849
Academic Journals
- 1,849
-
From:Future Virology (Vol. 9, Issue 7)Novel diagnostic approach may help identify the millions of individuals who are unknowingly infected. Each year, between 350,000 and 500,000 individuals die from hepatitis C (HCV)-related liver diseases, and while...
-
From:Clinical Advisor (Vol. 14, Issue 7)Patients with chronic hepatitis C infection had a greater than twofold risk of dying from both liver and non-liver-related causes compared with those who tested negative for the disease....
-
From:International Journal of Clinical Rheumatology (Vol. 7, Issue 2) Peer-ReviewedAuthor(s): Dimitrios Vassilopoulos [**] 2 , George V Papatheodoridis 1 KEYWORDS : anti-TNF agents; hepatitis B virus; hepatitis C virus; inflammatory bowel diseases; rheumatoid arthritis; spondyloarthropathies...
-
From:Expert Review of Anti-infective Therapy (Vol. 9, Issue 8) Peer-ReviewedAuthor(s): Ludovico Abenavoli [[dagger]] 1 , Piero L Almasio 2 Keywords : HCV; insulin resistance; interferon resistance; liver steatosis Approximately 170 million people worldwide are chronically infected...
-
From:The Brazilian Journal of Infectious Diseases (Vol. 13, Issue 4) Peer-ReviewedHCV infected patients frequently ask their physician about the risk of transmission to their partners. Although it is easy to answer that the risk does exist, it is difficult to quantify. We studied the transmission of...
-
From:Saudi Journal of Kidney Diseases and Transplantation (Vol. 19, Issue 5) Peer-ReviewedByline: Ghulam. Abbas, Shahid. Hussain, Tahir. Shafi To determine the efficacy of antiviral therapy in hepatitis C virus associated glome-rulopathy, we studied 30 patients with HCV-associated glomerulopathy at Sheikh...
-
From:Pediatrics (Vol. 105, Issue 4) Peer-ReviewedABBREVIATIONS. HCV, hepatitis C virus; NANB, non-A, non-B hepatitis; RIBA, recombinant immunoblot assay; HIV, human immunodeficiency virus; ALT, alanine aminotransferase; FDA, Food and Drug Administration. Ten years...
-
From:PLoS ONE (Vol. 7, Issue 7) Peer-ReviewedAuthor(s): Sergey A. Shiryaev 1 , Anton V. Cheltsov 2 , * , Alex Y. Strongin 1 , * Introduction Hepatitis C is a treatment-resistant disease with over 200 million people infected worldwide. Over 80% of infected...
-
From:PLoS ONE (Vol. 7, Issue 12) Peer-ReviewedAuthor(s): Satoshi Sekiguchi 1 , Kiminori Kimura 2 , Tomoko Chiyo 1 , Takahiro Ohtsuki 1 , Yoshimi Tobita 1 , Yuko Tokunaga 1 , Fumihiko Yasui 1 , Kyoko Tsukiyama-Kohara 3 , Takaji Wakita 4 , Toshiyuki Tanaka 5 ,...
-
From:PLoS ONE (Vol. 7, Issue 2) Peer-ReviewedAuthor(s): Ahmed El-Shamy 1 , 2 , Ikuo Shoji 1 , Soo-Ryang Kim 3 , Yoshihiro Ide 1 , Susumu Imoto 3 , Lin Deng 1 , Seitetsu Yoon 4 , Takashi Fujisawa 5 , Satoshi Tani 6 , Yoshihiko Yano 7 , Yasushi Seo 7 , Takeshi Azuma...
-
From:PLoS ONE (Vol. 7, Issue 12) Peer-ReviewedAuthor(s): Angelique P. A. Vermeiren 1 , * , Nicole H. T. M. Dukers-Muijrers 1 , 2 , Inge H. M. van Loo 2 , Frans Stals 3 , Dirk W. van Dam 4 , Ton Ambergen 5 , Christian J. P. A. Hoebe 1 , 2 Introduction...
-
From:PLoS ONE (Vol. 9, Issue 1) Peer-ReviewedAuthor(s): Cyrille Féray 1,*, Julie Bouscaillou 2, Bruno Falissard 3, Mostafa K. Mohamed 4, Naglaa Arafa 4, Iman Bakr 4, Mostafa El-Hoseiny 4, Mai El Daly 5,6, Sherif El-Kafrawy 5,6, Sabine Plancoulaine 7, Mohamed...
-
From:PLoS ONE (Vol. 8, Issue 7) Peer-ReviewedAuthor(s): Kristi Huik 1, Radko Avi 1, Andrew Carrillo 2,3, Nathan Harper 2,3, Merit Pauskar 1, Maarja Sadam 1, Tõnis Karki 1, Tõnu Krispin 1, Ulvi-Kaire Kongo 4, Tatiana Jermilova 5, Kristi Rüütel 6, Ave Talu 6, Katri...
-
From:PLoS ONE (Vol. 8, Issue 10) Peer-ReviewedAuthor(s): Youkyung Choi 1, Hans-Peter Dienes 2, Kris Krawczynski 1,* Introduction More than 170 million people world-wide are estimated to be chronically infected with HCV, and in the USA, about 25,000...
-
From:Emerging Infectious Diseases (Vol. 23, Issue 7) Peer-ReviewedLittle is known about concurrent infection with hepatitis C virus (HCV) and Streptococcus pneumoniae, which causes invasive pneumococcal disease (IPD). We hypothesized that co-infection with HCV and S. pneumoniae would...
-
From:Nature Medicine (Vol. 20, Issue 8) Peer-ReviewedOxidative tissue injury often accompanies viral infection, yet there is little understanding of how it influences virus replication. We show that multiple hepatitis C virus (HCV) genotypes are exquisitely sensitive to...
-
From:Science (Vol. 282, Issue 5390) Peer-ReviewedChronic hepatitis C virus (HCV) infection occurs in about 3 percent of the world's population and is a major cause of liver disease. HCV infection is also associated with cryoglobulinemia, a B lymphocyte proliferative...
-
From:Research Initiative/Treatment Action! (Vol. 20, Issue 2) Peer-ReviewedA list of osteoporosis risk factors compiled by the National Osteoporosis Foundation is long and detailed, yet it omits two factors confirmed by research and highly prevalent in people with HIV: HCV or HBV infection and...
-
From:Clinical Advisor (Vol. 17, Issue 3)Product: Sovaldi Company: Gilead Sciences Pharmacologic class: Hepatitis C virus (HCV) NS5B polymerase inhibitor. Active ingredient: Sofosbuvir 400mg; tabs. Indication: As a component of a combination...
-
From:PLoS ONE (Vol. 9, Issue 4) Peer-ReviewedBackground: Arterial blood pressure (BP) is a reliable marker of circulatory dysfunction in cirrhotic patients. There are no prospective studies evaluating the association between different levels of arterial BP and...